News & Updates

Premedication with low-dose oral midazolam in older patients undergoing a surgical procedure falls short of improving perioperative patient satisfaction, according to a study.

In the treatment of individuals with Alzheimer’s disease, acetylcholinesterase inhibitors (AChEIs) appear to confer a small reduction in the risk of age-related macular degeneration (AMD), as shown in a study.

Treatment-emergent (TE) antidrug antibodies (ADA) do not show any influence on the pharmacokinetics or efficacy of tirzepatide (TZP), as shown in a study. Most of the hypersensitivity or injection site reactions in patients with TE ADA are either mild or moderate in severity.

Zilebesiran, an investigational RNA interference therapeutic agent that targets hepatic angiotensinogen synthesis, appears to have a promising blood pressure (BP)-lowering effect in adults with mild-to-moderate hypertension, according to the phase II KARDIA-1 trial.

A prospective, multicentre study has demonstrated the efficacy of patch tests (PTs) for patients who are being treated with dupilumab.

Adults with inflammatory bowel disease (IBD) benefit from COVID-19 vaccination, with its protective effect lasting up to 52 weeks postvaccination even among vulnerable populations such as corticosteroid users and older individuals, according to a study.

Doubling the routine aspirin dose used for pre-eclampsia prevention appears to help lower the risk of developing pre-eclampsia with severe features among high-risk pregnant women with obesity, according to the results of the open-label ASPREO trial.